Research from The Cancer Institute of New Jersey on the FDA-approved drugs Celebrex(r) and Lipitor(r) -- used respectively for arthritis pain and lowering cholesterol -- shows that these drugs are well tolerated in the treatment of recurrent prostate cancer. Preliminary results from an ongoing Phase II clinical trial will be presented this week during the 2012 Genitourinary Cancers Symposium.

With the FDA accepting Pfizer's application for tofacitinib, a response should be out in August 2012.

FDA accepts application for Pfizer arthritis drug NEW YORK (AP) — Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.

(12-20) 11:29 PST NEW YORK, (AP) -- Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis....

Drugmaker Pfizer Inc. says the Food and Drug Administration has accepted its application for approval of its experimental drug for adults with moderate to severe rheumatoid arthritis.The FDA says it expects ...